ProfileGDS4718 / 225073_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 89% 92% 90% 93% 96% 95% 93% 90% 92% 94% 92% 93% 95% 96% 92% 92% 94% 96% 95% 90% 92% 91% 92% 92% 95% 92% 96% 90% 96% 96% 96% 91% 92% 94% 95% 95% 92% 91% 93% 93% 95% 95% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.5839592
GSM549102patient 115, normal, homogenized [OPG study]8.9982589
GSM549104patient 119, normal, homogenized [OPG study]9.5982892
GSM549108patient 138, normal, homogenized [OPG study]9.1284290
GSM549119patient 077, normal, homogenized [OPG study]9.7613693
GSM549133patient 032, cancer, homogenized [OPG study]10.569396
GSM549139patient 042, cancer, homogenized [OPG study]10.065595
GSM549099patient 107, normal, homogenized [OPG study]9.7756993
GSM549109patient 139, normal, homogenized [OPG study]9.2162190
GSM549110patient 046, normal, homogenized [OPG study]9.5732792
GSM549114patient 063, normal, homogenized [OPG study]10.141494
GSM549122patient 082, normal, homogenized [OPG study]9.5959992
GSM549134patient 033, cancer, homogenized [OPG study]9.8206293
GSM549136patient 036, cancer, homogenized [OPG study]10.213995
GSM549140patient 044, cancer, homogenized [OPG study]10.63596
GSM549111patient 047, normal, homogenized [OPG study]9.7052892
GSM549113patient 057, normal, homogenized [OPG study]9.6891492
GSM549132patient 031, cancer, homogenized [OPG study]10.023194
GSM549137patient 038, cancer, homogenized [OPG study]10.415496
GSM549142patient 047, cancer, homogenized [OPG study]9.701495
GSM549100patient 110, normal, homogenized [OPG study]9.0933790
GSM549107patient 135, normal, homogenized [OPG study]9.6283692
GSM549115patient 068, normal, homogenized [OPG study]9.6079391
GSM549116patient 072, normal, homogenized [OPG study]9.7376392
GSM549120patient 078, normal, homogenized [OPG study]9.6503392
GSM549131patient 030, cancer, homogenized [OPG study]10.259995
GSM549118patient 074, normal, homogenized [OPG study]9.6869592
GSM549129patient 027, cancer, homogenized [OPG study]10.373496
GSM549123patient 088, normal, homogenized [OPG study]9.3310190
GSM549124patient 006, cancer, homogenized [OPG study]10.428496
GSM549126patient 015, cancer, homogenized [OPG study]10.302496
GSM549128patient 025, cancer, homogenized [OPG study]10.367996
GSM549103patient 117, normal, homogenized [OPG study]9.3367991
GSM549117patient 073, normal, homogenized [OPG study]9.7990792
GSM549138patient 041, cancer, homogenized [OPG study]10.043494
GSM549141patient 045, cancer, homogenized [OPG study]10.287695
GSM549130patient 028, cancer, homogenized [OPG study]10.090695
GSM549101patient 111, normal, homogenized [OPG study]9.5104692
GSM549105patient 128, normal, homogenized [OPG study]9.3850191
GSM549106patient 134, normal, homogenized [OPG study]9.8768793
GSM549112patient 048, normal, homogenized [OPG study]9.7454893
GSM549125patient 011, cancer, homogenized [OPG study]10.172295
GSM549127patient 024, cancer, homogenized [OPG study]10.021495
GSM549135patient 035, cancer, homogenized [OPG study]9.7477293